Shirley Mo

505 total citations
11 papers, 178 citations indexed

About

Shirley Mo is a scholar working on Surgery, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Shirley Mo has authored 11 papers receiving a total of 178 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 3 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Shirley Mo's work include Lymphoma Diagnosis and Treatment (3 papers), CNS Lymphoma Diagnosis and Treatment (2 papers) and Bariatric Surgery and Outcomes (2 papers). Shirley Mo is often cited by papers focused on Lymphoma Diagnosis and Treatment (3 papers), CNS Lymphoma Diagnosis and Treatment (2 papers) and Bariatric Surgery and Outcomes (2 papers). Shirley Mo collaborates with scholars based in United States, Australia and Malaysia. Shirley Mo's co-authors include Eric Kofman, Eliezer M. Van Allen, Jake R. Conway, Haitham Elmarakeby, Michael Talbot, Georgia Rigas, Oliver M. Fisher, Jia Liu, Thuvarahan Jegathees and D. W. Fahey and has published in prestigious journals such as Blood, Neurology and The Laryngoscope.

In The Last Decade

Shirley Mo

8 papers receiving 178 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shirley Mo United States 6 82 45 45 42 35 11 178
Kasper Madsen Denmark 8 123 1.5× 29 0.6× 39 0.9× 36 0.9× 68 1.9× 32 255
Daniel Drescher Germany 9 94 1.1× 50 1.1× 32 0.7× 62 1.5× 66 1.9× 14 239
Marlies Schrevel Netherlands 6 87 1.1× 60 1.3× 52 1.2× 21 0.5× 79 2.3× 8 319
Cara Cimmino United States 7 129 1.6× 22 0.5× 131 2.9× 33 0.8× 48 1.4× 12 281
Benito Fabio Mirto Italy 6 43 0.5× 82 1.8× 13 0.3× 57 1.4× 66 1.9× 13 222
Karl-Heinz Jöckel Germany 4 60 0.7× 24 0.5× 16 0.4× 84 2.0× 74 2.1× 5 207
Josef Chovanec Czechia 9 86 1.0× 21 0.5× 58 1.3× 37 0.9× 74 2.1× 23 275
Sandrine Oziel-Taïeb France 7 97 1.2× 27 0.6× 19 0.4× 42 1.0× 27 0.8× 19 247
Anna H. Wu United States 5 67 0.8× 109 2.4× 18 0.4× 17 0.4× 85 2.4× 7 278
Sarah A. McGarrigle Ireland 10 70 0.9× 48 1.1× 18 0.4× 66 1.6× 93 2.7× 16 246

Countries citing papers authored by Shirley Mo

Since Specialization
Citations

This map shows the geographic impact of Shirley Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shirley Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shirley Mo more than expected).

Fields of papers citing papers by Shirley Mo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shirley Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shirley Mo. The network helps show where Shirley Mo may publish in the future.

Co-authorship network of co-authors of Shirley Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Shirley Mo. A scholar is included among the top collaborators of Shirley Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shirley Mo. Shirley Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Mo, Shirley, Alexander J. Ambinder, Amy E. DeZern, et al.. (2025). DNMT3A, NPM1, and FLT3-ITD triple-mutated AML has a favorable prognosis in the era of FLT3 inhibitors. Blood. 146(Supplement 1). 1710–1710.
2.
Geng, Huimin, Shirley Mo, Lingjing Chen, et al.. (2024). Identification of genomic biomarkers of disease progression and survival in primary CNS lymphoma. Blood Advances. 9(5). 1117–1131.
3.
Fisher, Oliver M., et al.. (2023). The role of adjuvant pharmacotherapy with liraglutide for patients with inadequate weight loss following bariatric surgery. Langenbeck s Archives of Surgery. 408(1). 115–115. 20 indexed citations
5.
Mo, Shirley, Joseph C. Cleveland, & James L. Rubenstein. (2022). Primary CNS lymphoma: update on molecular pathogenesis and therapy. Leukemia & lymphoma. 64(1). 57–65. 4 indexed citations
6.
Gao, Yijun, Shirley Mo, Georgia Rigas, et al.. (2022). Fertility, pregnancy and post partum management after bariatric surgery: a narrative review. The Medical Journal of Australia. 216(2). 96–102. 11 indexed citations
7.
Huang, Linfeng, Padraig Deighan, Jingmin Jin, et al.. (2020). Tombusvirus p19 Captures RNase III-Cleaved Double-Stranded RNAs Formed by Overlapping Sense and Antisense Transcripts in Escherichia coli. mBio. 11(3). 5 indexed citations
8.
Amorim, Edilberto, Shirley Mo, Sebastian Palacios, et al.. (2020). Cost-effectiveness analysis of multimodal prognostication in cardiac arrest with EEG monitoring. Neurology. 95(5). e563–e575. 3 indexed citations
9.
Mo, Shirley, Aneeza Khairiyah Wan Hamizan, Janet Rimmer, et al.. (2020). Nasal Peak Inspiratory Flow in Healthy and Obstructed Patients: Systematic Review and Meta‐Analysis. The Laryngoscope. 131(2). 260–267. 11 indexed citations
10.
Conway, Jake R., Eric Kofman, Shirley Mo, Haitham Elmarakeby, & Eliezer M. Van Allen. (2018). Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine. Genome Medicine. 10(1). 93–93. 113 indexed citations
11.
Mo, Shirley, et al.. (2017). Retrospective Analysis of Patient Presentations at the Sydney (Australia) Royal Easter Show from 2012 to 2014. Prehospital and Disaster Medicine. 32(2). 187–194. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026